Ignite Creation Date:
2024-05-06 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03357263
Status:
COMPLETED
Last Update Posted:
2018-11-19
First Post:
2017-11-24
Brief Title:
A Study to Evaluate the Safety and EfficacyImmunogenicity of GC3114 in Healthy Adults
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
Randomized Single-Blind Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults
Status:
COMPLETED
Status Verified Date:
2018-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Healthy adults will be once administered GC3114AHigh-dose Quadrivalent influenza vaccine or GCFLU Quadrivalent Pre-filled syringe inj
Detailed Description:
Healthy adults will be once administered GC3114AHigh-dose Quadrivalent influenza vaccine or GCFLU Quadrivalent Pre-filled syringe inj Safety and immunological efficacy will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None